Protech Biopharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.00 M
- Company Age 17 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.97 Cr
- Revenue Growth -35.57%
- Profit Growth -61.45%
- Ebitda -61.63%
- Net Worth -6.96%
- Total Assets -15.22%
About Protech Biopharma
Protech Biopharma Private Limited (PBPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 November 2007 and has a history of 17 years and two months. Its registered office is in Srinagar, Jammu & Kashmir, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.97 Cr.
Waheed Rehman and Abdul Mir serve as directors at the Company.
Company Details
-
Location
Srinagar, Jammu & Kashmir, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233JK2007PTC002841
-
Company No.
002841
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Nov 2007
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jammu
Industry
What products or services does Protech Biopharma Private Limited offer?
Protech Biopharma Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antiparasitic Drug.
Who are the key members and board of directors at Protech Biopharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Waheed Rehman
|
Managing Director | 15-Nov-2007 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Abdul Mir
|
Director | 14-Dec-2021 | Current |
Financial Performance of Protech Biopharma.
Protech Biopharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 35.57% decrease. The company also saw a substantial fall in profitability, with a 61.45% decrease in profit. The company's net worth dipped by a decrease of 6.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Protech Biopharma?
In 2019, Protech Biopharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Denovo Engineering Private LimitedWaheed Rehman is a mutual person
Charges (Loans)
₹19.73 M
₹0
Charges Breakdown by Lending Institutions
- Jammu And Kashmir Bank : 1.51 Cr
- The Jammu And Kashmir Bank Limited : 0.41 Cr
- Hdfc Bank Limited : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Sep 2022 | The Jammu And Kashmir Bank Limited | ₹0.26 M | Open |
| 14 Dec 2021 | The Jammu And Kashmir Bank Limited | ₹2.60 M | Open |
| 23 Nov 2021 | Hdfc Bank Limited | ₹0.57 M | Open |
| 28 Nov 2017 | The Jammu And Kashmir Bank Limited | ₹0.30 M | Open |
| 29 Nov 2013 | The Jammu And Kashmir Bank Limited | ₹0.23 M | Open |
How Many Employees Work at Protech Biopharma?
Unlock and access historical data on people associated with Protech Biopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Protech Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Protech Biopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
